Home >> OnDemandWebinarsListenGuide >> Community-based rapid NGS offers considerable advantages in clinical cancer care

Community-based rapid NGS offers considerable advantages in clinical cancer care

image_pdfCreate PDF

Dr. Sheffield

Webinar presenter Brandon Sheffield, MD, Anatomic and Molecular Pathologist, Department of Laboratory Medicine, William Osler Health System, discusses William Osler Health System’s experience with implementing next-generation sequencing (NGS) in routine oncology biomarker testing. In their pilot study, 578 pan-cancer solid tumor samples underwent genomic profiling. All testing was performed by one group of technologists within the same division of the laboratory, achieving a median turnaround time (TAT) of 3 business days. Dr. Sheffield will elaborate on the importance of timely availability of biomarker results for optimal cancer care, demostrate the feasibility of such TATs in community-based hospitals using fast and automated NGS, and describe the novel approach of integrating NGS with routine immunohistochemistry.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY.

CAP TODAY
X